schestowitz@joindiaspora.com
Dr. Roy Schestowitz

Another example of JUVE #marketing #spam (for #patent #litigation company) disguised as reporting on #patents https://www.juve-patent.com/news-and-stories/cases/french-pi-over-pemetrexed-confirmed-but-new-view-on-provisional-damages/ see http://techrights.org/wiki/index.php/Juve

French PI over pemetrexed confirmed, but new view on provisional damages - JUVE Patent

Paris Court of Appeal upholds Eli Lilly's preliminary injunction against Zentiva but reversed the decision on €4 million provisional damages.

There are no comments yet.